Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
May 1, 2024Nephrology Dialysis TransplantationOpen Access

#2638 SGLT2i in CKD with high albuminuria: an observational real-world study

View Full Paper
Ask AI
Bookmark
Share

Authors

MSMaria SvenssonJBJohan BodegårdMTMarcus Thuresson

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Svensson et al. (2024) studied this question.

synapsesocial.com/papers/68e6c82cb6db6435876465e2https://doi.org/10.1093/ndt/gfae069.147
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1#150 Effect of dapagliflozin in patients with CKD depending on primary kidney disease2024
  2. 2#1549 The effect of sglt2 inhibitors (dapaglifozin) on albuminuria in patients of diabetic nephropathy above standard of care2024
  3. 3Effects of Dapagliflozin in Patients with Membranous Nephropathy2024 · 3 citations
  4. 4#1868 Dapagliflozin reduces urinary kidney injury biomarkers in chronic kidney disease irrespective of albuminuria level2024
  5. 5#1042 A real-life experience with dapagliflozin in the treatment of patients with IgA Nephropathy at high risk of progression2024